ITIL-306

N/A

Report date: 2026/04/17 10:35:57

Base Information

Drug NameITIL-306

Drug Alias NameCoStAR-TIL (Instil Bio)ITIL-306

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes

Mechanisms of ActionAnti-FOLR1

TargetsFolate receptor alpha

Therapy Area/IndicationsSolid tumoursGenital Neoplasms, FemaleCarcinoma, Non-Small-Cell Lung +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesInstil Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesInstil Bio Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursGenital Neoplasms, Female

Inactive IndicationsCarcinoma, Non-Small-Cell LungCarcinoma, Ovarian EpithelialCarcinoma, Renal Cell

Other Information

ATC CodeN/A